RKLB Stock Tumbles Over 8% Overnight as Neutron Delays Overshadow Record Revenue — but Analyst Sees Rocke
RKLB Stock Tumbles Over 8% Overnight as Neutron Delays Overshadow Record Revenue — but Analyst Sees Rocke Benzinga
Covered in this story
Analyst targets on Rocket Lab
- Needham: at $55.3 · target $120 by Oct 2027 · Buy via Investing.com
- Citizens JMP: at $55.3 · target $90 by Oct 2027 · Market Outperform via Investing.com
- KeyBanc Capital Markets: at $52.9 · target $100 by Oct 2027 · Overweight via Investing.com
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $RKLB yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Rocket Lab →Dalsna Finance is currently tracking 49 stories mentioning Rocket Lab, the earliest published 1 Jun 2026.
Summary aggregated from Benzinga's public RSS feed. The full reporting belongs to Benzinga — please read it on their site.